# Corteva, Inc.: overview

CTVA · NYSE · CIK 1755672 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ctva.md) · [Financials](/companies/ctva/financials.md) · [Filings](/companies/ctva/filings.md) · [Insiders](/companies/ctva/insiders.md)

Latest reported revenue: [$6.38bn](/filings/0001755672-26-000025.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 31, 2026 (XBRL us-gaap:Revenues, accession 0001755672-26-000025).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,326](/filings/0001755672-25-000022.md) | [3,978 d](/filings/0001755672-26-000004.md) | [4,417](/filings/0001755672-26-000010.md) | [6,456](/filings/0001755672-26-000025.md) | [2,618](/filings/0001755672-25-000022.md) | [3,910 d](/filings/0001755672-26-000004.md) | [4,905](/filings/0001755672-26-000010.md) | [6,379](/filings/0001755672-26-000025.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [(22.5%)](/filings/0001755672-25-000022.md) | [(1.0%) d](/filings/0001755672-26-000004.md) | [14.8%](/filings/0001755672-26-000010.md) | [20.4%](/filings/0001755672-26-000025.md) | [(12.2%)](/filings/0001755672-25-000022.md) | [(14.1%) d](/filings/0001755672-26-000004.md) | [14.7%](/filings/0001755672-26-000010.md) | [18.2%](/filings/0001755672-26-000025.md) |
| Diluted EPS | $ per share | [(0.76)](/filings/0001755672-25-000022.md) | not reported | [0.95](/filings/0001755672-26-000010.md) | [1.92](/filings/0001755672-26-000025.md) | [(0.47)](/filings/0001755672-25-000022.md) | not reported | [1.07](/filings/0001755672-26-000010.md) | [1.73](/filings/0001755672-26-000025.md) |
| Free cash flow | $m | [(24.0) d](/filings/0001755672-25-000022.md) | [3,992 d](/filings/0001755672-26-000004.md) | [(2,203)](/filings/0001755672-26-000010.md) | [829 d](/filings/0001755672-26-000025.md) | [36.0 d](/filings/0001755672-25-000022.md) | [4,153 d](/filings/0001755672-26-000004.md) | [(2,972)](/filings/0001755672-26-000010.md) | [(588) d](/filings/0001755672-26-000025.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [15.7](/filings/0001755672-24-000004.md) | [17.5](/filings/0001755672-25-000005.md) | [17.2](/filings/0001755672-26-000004.md) | [16.9](/filings/0001755672-26-000004.md) | [17.4](/filings/0001755672-26-000004.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [11.2%](/filings/0001755672-24-000004.md) | [6.6%](/filings/0001755672-25-000005.md) | [4.3%](/filings/0001755672-26-000004.md) | [5.4%](/filings/0001755672-26-000004.md) | [6.3%](/filings/0001755672-26-000004.md) |
| Diluted EPS | $ per share | [2.37](/filings/0001755672-24-000004.md) | [1.58](/filings/0001755672-25-000005.md) | [1.03](/filings/0001755672-26-000004.md) | [1.30](/filings/0001755672-26-000004.md) | [1.60](/filings/0001755672-26-000004.md) |
| Free cash flow | $bn | [2.2](/filings/0001755672-24-000004.md) | [0.3](/filings/0001755672-25-000005.md) | [1.2](/filings/0001755672-26-000004.md) | [1.5](/filings/0001755672-26-000004.md) | [2.8](/filings/0001755672-26-000004.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ctva/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $4.56bn | 53,845,550 |  | Reduced −864,902 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $3.71bn | 43,792,285 |  | Reduced −283,569 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $3.64bn | 42,923,729 |  | Added +6,925,682 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $3.48bn | 41,072,288 |  | Added +6,100,388 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $3.24bn | 38,261,197 |  | Added +2,123,158 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $2.52bn | 29,803,789 |  | Reduced −257,999 |
| [FRANKLIN RESOURCES INC](/funds/38777.md) | 2026-06-30 | $1.89bn | 22,332,489 |  | Added +537,882 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.59bn | 18,899,903 |  | Added +176,582 |
| [Aristotle Capital Management, LLC](/funds/860644.md) | 2026-06-30 | $1.50bn | 17,768,547 |  | Reduced −1,065,165 |
| [HARRIS ASSOCIATES L P](/funds/813917.md) | 2026-06-30 | $1.38bn | 16,333,110 |  | Reduced −323,023 |

## Recent filings

[All 603 filings](/companies/ctva/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-07-30 | 20:44 ET | [8-K](/filings/0001755672-26-000022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001755672-26-000022 |
| 2026-06-29 | 21:23 ET | [8-K](/filings/0001193125-26-288755.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-288755 |
| 2026-06-12 | 21:24 ET | [8-K/A](/filings/0001755672-26-000020.md) | 2.05 Exit or disposal costs; 2.06 Material impairments | 0001755672-26-000020 |
| 2026-05-05 | 20:41 ET | [8-K](/filings/0001755672-26-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001755672-26-000008 |
| 2026-05-01 | 20:21 ET | [8-K](/filings/0001755672-26-000006.md) | 5.07 Shareholder vote results | 0001755672-26-000006 |
| 2026-04-14 | 12:35 ET | [8-K](/filings/0001193125-26-153947.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-153947 |
| 2026-03-19 | 20:31 ET | [DEF 14A](/filings/0001193125-26-116069.md) | Proxy statement, period 2026-04-28 | 0001193125-26-116069 |
| 2026-02-03 | 21:44 ET | [8-K](/filings/0001755672-26-000002.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001755672-26-000002 |
| 2025-11-04 | 21:40 ET | [8-K](/filings/0001755672-25-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001755672-25-000020 |
| 2025-10-01 | 10:55 ET | [8-K](/filings/0001193125-25-225842.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-225842 |

## Latest annual report

No annual report is in coverage.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/dedf6425-7ba3-4cba-b51b-247ded6bf9eb)

## About the filer

- CIK: 1755672
- Tickers: CTVA
- Exchange: NYSE
- SIC code: 100 Agricultural Production-Crops
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.